Literature DB >> 18036757

An oxcarbazepine-related fatality with an overview of 26 oxcarbazepine postmortem cases.

Kristian Linnet1, Anni Steentoft, Kirsten W Simonsen, Anne Sabers, Steen Holger Hansen.   

Abstract

We present an oxcarbazepine-related fatality together with an overview of 26 postmortem cases involving oxcarbazepine observed during the period 2001-2006. The fatality case concerned a 27-year-old woman with epilepsy, who was found dead in her bed. Oxcarbazepine and its active metabolite, 10-hydroxycarbazepine, were the only compounds detected. The concentrations of oxcarbazepine were as follows: femoral blood, 2.9mg/kg; muscle, 1.8mg/kg; liver, 0.9mg/kg; gastric content (300ml), 860mg/kg; and vitreous humour, not detected. The concentrations of 10-hydroxycarbazepine were as follows: femoral blood, 66mg/kg; muscle, 40mg/kg; liver, 62mg/kg; gastric content, 27mg/kg; and vitreous humour, 25mg/kg. The analyses were performed by HPLC-DAD after liquid-liquid extraction. Oxcarbazepine intoxication was regarded as a possible cause of death. For the other 26 cases, the 10-hydroxycarbazepine concentrations ranged from 2.2 to 48mg/kg with a median of 25mg/kg.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18036757     DOI: 10.1016/j.forsciint.2007.10.002

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  2 in total

1.  The onset of acute oxcarbazepine toxicity related to prescription of clarithromycin in a child with refractory epilepsy.

Authors:  Raoul Santucci; Helen Fothergill; Vincent Laugel; Anne Perville; Anne De Saint Martin; Anne-Cécile Gerout; Michel Fischbach
Journal:  Br J Clin Pharmacol       Date:  2010-03       Impact factor: 4.335

2.  Vitreous humor analysis for the detection of xenobiotics in forensic toxicology: a review.

Authors:  Fabien Bévalot; Nathalie Cartiser; Charline Bottinelli; Laurent Fanton; Jérôme Guitton
Journal:  Forensic Toxicol       Date:  2015-10-28       Impact factor: 4.096

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.